Our Research Results

Since we first began more than 40 years ago, Breast Cancer Trials (BCT) has contributed to more than 1,200 peer-reviewed publications and many of these research results have changed practice in the treatment and prevention of breast cancer.

The publication of the results of clinical trials research in a scientific journal or a periodic publication:

  • Fulfils the researchers’ ethical obligations to research participants and the general community;
  • Contributes to medical knowledge so doctors can make scientifically valid assessments of the benefits and risks of a new medicine or treatment for their patients.

BCT publishes study results in accordance with the BCT Publication Policy.

The citations for all of these publications are listed below, ordered by year. To search for a citation, enter a keyword/s and click search. Enclose multiple words in quotes “” to search for an exact match. Alternatively, you can search for clinical trials in a given year or for a particular clinical trial name. 

The majority of the publications can be accessed via PubMed, other research databases or publication storage systems at a university library (if you are a student/member), or directly to the journal or publication online. Many scientific journals provide articles as “open access”; however some require a subscription.

Become a Member

Are you actively involved in the conduct of breast cancer clinical trials research? Become a member today!

Become a Member

PUBLICATIONS

2025

Quality of Life and Fear of Recurrence or Progression in Women with DCIS Who Did and Did Not Receive Radiotherapy [BCT Clinical Fellowship].

Sinclair M, Mann GB, Kozul C, Park A, Stafford L. Clinical Breast Cancer. 2025; https://doi.org/10.1016/j.clbc.2025.11.001, E-pub

Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational study.

Marinovich ML, Houssami N, Spillane A, Mann GB, Taylor D, Reintals M, Phillips N, Bulsara MK, Soon PSH, Dickens T, Saunders CM. Medical Journal of Australia. 2025; 223(11):602-610, epub 24 Sept 2025. doi: 10.5694/mja2.70051., Journal

Assessment of adjuvant endocrine therapy with ovarian function suppression by Breast Cancer Index.

O’Regan RM, Ren Y, Zhang Y, Siuliukina N, Schnabel CA, Kammler R, Viale G, Dell’Orto P, Munzone E, Lang I, Tondini C, Gomez HL, Chini C, Nicoletti SVL, Puglisi F, Zaman K, Goetz MP, Stearns V, Martino S, Salim M, Loibl S, Geyer CE, Bennefoi HR, Ciruelos EV, Loi S, Colleoni M, Fleming GF, Francis PA, Walley BA, Pagani O, Treuner K, Regan MM. JAMA Network Open. 2025; 8(11):e2540931, doi:10.1001/jamanetworkopen.2025.40931, E-pub

Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.

Ribi K, Cole BF, Fleming GF, Walley BA, Francis PA, Abdi E, Burstein HJ, Cheng KL, Chia SKL, Dakhil SR, Davidson NE, Della-Fiorentina SA, Frith AE, Levine E, Lupichick S, Pritchard K, Salim M, Stearns V, Stewart J, Valero V, dan der Westhuizen A, Pagani O, Loi S, Colleoni M, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J. Cancer 2025; e70094 E-pub

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Gacia AJ, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Maijaj S, Kammler R, Colleoni M, Loi S, viale G, Regan MM, Rothe F, Sotirious C, Ueno NT. iScience. 2025; 28(8):112964, epub 15 August 2025., E-pub

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection. [BCT Clinical Fellowship].

Sokolova A, Joshi V, Chittoory H, Walsh M, Lim M, Kutasovic JR, Ferguson K, Simpson PT, Lakhani SR, McCart Reed AE. Histopathology 2025; 87223-234, https://doi.org/10.1111/his.15465, E-pub

Load more

Total Publications: 1358